Molecular tumour markers could reveal new therapeutic targets for lung cancer treatment
Analysis of 607 small cell lung cancer (SCLC) lung tumours and neuroendocrine tumours (NET) identified common molecular markers among both groups that could reveal new therapeutic targets for patients with similar types of lung cancer, according to research. This study examined the clinical specimens of 607 total cases of SCLC tumours (375) and lung NET […]
